Home › Research › Cognitive tests and assessment
Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity
Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative.. Psychiatry research, 2011-09-14
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Despite numerous studies on the role of medial temporal lobe structures in Alzheimer's disease (AD), the magnitude and clinical significance of amygdala atrophy have been relatively sparsely investigated. In this study, we used magnetic resonance imaging (MRI) to compare the level of amygdala atrophy to that of the hippocampus in very mild and mild AD subjects in two large samples (Sample 1 n=90; Sample 2 n=174). Using a series of linear regression analyses, we investigated whether amygdala atrophy is related to global cognitive functioning (Clinical Dementia Rating Sum of Boxes: CDR-SB; Mini Mental State Examination: MMSE) and neuropsychiatric status.
What this study adds
Evidence grade: Low
The record lists 90 participants. This imaging study compared amygdala atrophy with hippocampus atrophy in very mild and mild Alzheimer's disease and examined whether amygdala atrophy relates to cognitive and neuropsychiatric status. It is an observational study of brain structure and symptom severity, not a treatment, cure, or prevention study.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Poulin, S. P., Dautoff, R., Morris, J. C., Barrett, L. F., Dickerson, B. C., & Alzheimer's Disease Neuroimaging Initiative. (2011). Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity. Psychiatry research. https://doi.org/10.1016/j.pscychresns.2011.06.014
Vancouver
Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative. Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity. Psychiatry research. 2011. doi:10.1016/j.pscychresns.2011.06.014. PMID: 21920712.
BibTeX
@article{poulin2011-21920712,
author = {Poulin, S. P. and Dautoff, R. and Morris, J. C. and Barrett, L. F. and Dickerson, B. C. and {Alzheimer's Disease Neuroimaging Initiative}},
title = {{Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity}},
journal = {Psychiatry research},
year = {2011},
doi = {10.1016/j.pscychresns.2011.06.014},
pmid = {21920712},
url = {https://doi.org/10.1016/j.pscychresns.2011.06.014}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- In this study, we used magnetic resonance imaging (MRI) to compare the level of amygdala atrophy to that of the hippocampus in very mild and mild AD subjects in two large samples (Sample 1 n=90; Sample 2 n=174).
- Using a series of linear regression analyses, we investigated whether amygdala atrophy is related to global cognitive functioning (Clinical Dementia Rating Sum of Boxes: CDR-SB; Mini Mental State Examination: MMSE) and neuropsychiatric status.
- Results indicated that amygdala atrophy was comparable to hippocampal atrophy in both samples.
- MMSE and CDR-SB were strongly related to amygdala atrophy, with amygdala atrophy predicting MMSE scores as well as hippocampal atrophy, but predicting CDR-SB scores less robustly.
Why it matters
This imaging study compared amygdala atrophy with hippocampus atrophy in very mild and mild Alzheimer's disease and examined whether amygdala atrophy relates to cognitive and neuropsychiatric status. It is an observational study of brain structure and symptom severity, not a treatment, cure, or prevention study.
Study details
- Participants90
- Evidence strengthLow
How this study scored 55/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 53 of the 96 points we could judge it on, which is 55 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Psychiatry research) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2011 — within 20 year(s) of the newest study here |
| Sample size | 1 / 4 | 90 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 452 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 26.6 citations a year over 17 year(s) since 2011 |
| Impact for its field and year | 4 / 6 | Cited 8.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 15 other studies in this library |
| Still being cited | 3 / 4 | Cited 123 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Bradford Clark Dickerson: h-index 90 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 21920712) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 53 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 53 of the 96 points we could judge it on is 55 out of 100. |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.pscychresns.2011.06.014
- PubMed: 21920712
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
15 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Cognitive tests and assessment from nearby years
Also in Cognitive tests and assessment
92 studies in the library are filed under Cognitive tests and assessment with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Cognitive tests and assessment hub.